LUPUS ANTICOAGULANT ACTIVITY OF SOME ANTIPHOSPHOLIPID ANTIBODIES AGAINST PHOSPHOLIPID BOUND BETA(2)-GLYCOPROTEIN-I

被引：19

作者：

KEELING, DM

WILSON, AJG

MACKIE, IJ

ISENBERG, DA

MACHIN, SJ

机构：

[1] UNIV COLL & MIDDLESEX SCH MED,DEPT HAEMATOL,LONDON,ENGLAND

[2] UNIV COLL & MIDDLESEX SCH MED,DEPT RHEUMATOL,LONDON,ENGLAND

来源：

JOURNAL OF CLINICAL PATHOLOGY | 1993年 / 46卷 / 07期

关键词：

D O I：

10.1136/jcp.46.7.665

中图分类号：

R36 [病理学];

学科分类号：

100104 ;

摘要：

Aims-To determine whether beta2 glycoprotein I (beta2GPI) dependent anticardiolipin (aCL) antibodies detected in solid phase enzyme linked immunosorbent assays can also have lupus anticoagulant activity. Methods-Six anticardiolipin antibodies were affinity purified from patients with these antibodies and lupus anticoagulant activity in their plasma. Results-The anticardiolipin antibodies bound only to anionic phospholipids in the presence of beta2GPI and bound to beta2GPI in the absence of phospholipids. Four out of six had lupus anticoagulant activity in the dilute Russell viper venom time test. Conclusions-The results show that some beta2GPI dependent aCL are lupus anticoagulants. It is unclear why only some should have lupus anticoagulant activity while others do not.

引用

页码：665 / 667

页数：3

共 50 条

[31] ANTI-BETA(2)-GLYCOPROTEIN-I ANTIBODIES AND THROMBOSIS
VIARD, JP
AMOURA, Z
BACH, JF
CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY, 1995, 13 (01) : 67 - 72
[32] Monoclonal antibodies against beta-2-glycoprotein I: Use as reference material for lupus anticoagulant tests
Arnout, J
Vanrusselt, M
Wittevrongel, C
Vermylen, J
THROMBOSIS AND HAEMOSTASIS, 1998, 79 (05) : 955 - 958
[33] HETEROGENEITY OF ANTI-BETA(2)-GLYCOPROTEIN-I ANTIBODIES
SANMARCO, M
SOLER, C
NOUVELLE REVUE FRANCAISE D HEMATOLOGIE, 1995, 37 : S57 - S60
[34] Clinical relevance of anticardiolipin, anti-beta(2)glycoprotein-I, anti-prothrombin antibodies and lupus anticoagulant in systemic lupus erythematosus (SLE) patients
Swadzba, J
DeClerck, LS
Stevens, WJ
Bridts, CH
vanCotthem, KA
Musial, J
Jankowski, M
Szczeklik, A
THROMBOSIS AND HAEMOSTASIS, 1997, : P2214 - P2214
[35] SYNCHRONIZED INHIBITION OF THE PHOSPHOLIPID MEDIATED AUTOACTIVATION OF FACTOR-XII IN PLASMA BY BETA(2)-GLYCOPROTEIN-I AND ANTI-BETA(2)-GLYCOPROTEIN-I
SCHOUSBOE, I
RASMUSSEN, MS
THROMBOSIS AND HAEMOSTASIS, 1995, 73 (05) : 798 - 804
[36] CLINICAL MANIFESTATIONS OF THE ANTIPHOSPHOLIPID SYNDROME IN PATIENTS WITH SYSTEMIC LUPUS-ERYTHEMATOSUS ASSOCIATE MORE STRONGLY WITH ANTI-BETA(2)-GLYCOPROTEIN-I THAN WITH ANTIPHOSPHOLIPID ANTIBODIES
CABIEDES, J
CABRAL, AR
ALARCONSEGOVIA, D
JOURNAL OF RHEUMATOLOGY, 1995, 22 (10) : 1899 - 1906
[37] ANTIPHOSPHOLIPID AND ANTI-BETA-2 GLYCOPROTEIN-I ANTIBODIES IN SNEDDON SYNDROME (SNS) - STUDY OF 16 CASES
FRANCES, C
VIARD, JP
PIETTE, JC
BERARD, M
BLETRY, O
TOURBAH, A
BOFFA, MC
GODEAU, P
ARTHRITIS AND RHEUMATISM, 1992, 35 (09): : S157 - S157
[38] THE BETA-2-GLYCOPROTEIN-I AND ANTIPHOSPHOLIPID ANTIBODIES
SHOENFELD, Y
MERONI, PL
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 1992, 10 (02) : 205 - 209
[39] DO PATIENTS WITH ANTIPHOSPHOLIPID SYNDROME HAVE AUTOANTIBODIES TO BETA(2)-GLYCOPROTEIN-I
GHARAVI, AE
HARRIS, EN
SAMMARITANO, LR
PIERANGELI, SS
WEN, JY
JOURNAL OF LABORATORY AND CLINICAL MEDICINE, 1993, 122 (04): : 426 - 431
[40] INCREASED LEVELS OF BETA-2 GLYCOPROTEIN-I ANTIGEN AND BETA-2 GLYCOPROTEIN-I BINDING-ANTIBODIES ARE ASSOCIATED WITH A HISTORY OF THROMBOEMBOLIC COMPLICATIONS IN PATIENTS WITH SLE AND PRIMARY ANTIPHOSPHOLIPID SYNDROME
MCNALLY, T
MACKIE, IJ
ISENBERG, DA
MACHIN, SJ
THROMBOSIS AND HAEMOSTASIS, 1995, 73 (06) : 1264 - 1264

← 1 2 3 4 5 →